Here's What Key Metrics Tell Us About Amdocs (DOX) Q2 Earnings

For the quarter ended March 2026, Amdocs (DOX) reported revenue of $1.17 billion, up 3.9% over the same period last year. EPS came in at $1.78, compared to $1.78 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $1.17 billion, representing a surprise of +0.44%. The company delivered an EPS surprise of +0.85%, with the consensus EPS estimate being $1.77.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Amdocs performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Geographic Revenue- North America: $754.3 million versus $769.07 million estimated by two analysts on average.Geographic Revenue- Rest of the World: $225.8 million versus $204.24 million estimated by two analysts on average.Geographic Revenue- Europe: $191.8 million versus $192.49 million estimated by two analysts on average.View all Key Company Metrics for Amdocs here>>>Shares of Amdocs have returned -4.1% over the past month versus the Zacks S&P 500 composite's +8.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks